Synthetic cannabinoid and marijuana exposures reported to poison centers

Human and Experimental Toxicology

Volumn 31, Issue 10, 2012, Pages 1006-1011

  Forrester, M B ^a   Kleinschmidt, K ^b   Schwarz, E ^b   Young, A ^b  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

marijuana; poison center; synthetic cannabinoid

Indexed keywords

CANNABINOID DERIVATIVE; CANNABIS; SYNTHETIC CANNABINOID; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; FEMALE; HOME; HUMAN; INHALATION; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POISON CENTER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; CANNABINOIDS; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; ODDS RATIO; POISON CONTROL CENTERS; POISONING; PRESCRIPTION DRUG MISUSE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; TEXAS; YOUNG ADULT;

EID: 84867519144     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111421945     Document Type: Article

References (24)

1. Green B, Kavanagh D, Young R. Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev. 2003 ; 22: 453-460
2. Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010 ; 197: 157-162
3. Schedules of controlled substances: temporary placement of five synthetic cannabinoids into Schedule I. Microgram Bull. 2011 ; 44: 1-5
4. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med. 2011 ; 40: 296-299
5. Vearrier D, Osterhoudt K. A teenager with agitation-higher than she should have climbed. Pediatr Emerg Care. 2010 ; 26: 462-464
6. Hermanns-Clausen M, Sauer O, Gerber G, Faerber E, Koch IE, Hentschel H, et al. New "herbal drugs" of abuse: spice and smoke. Clin Toxicol. 2009 ; 47: 452
7. European Monitoring Centre for Drugs and Drug Addiction. Synthetic cannabinoids and 'spice'. Available athttp://www.emcdda.europa.eu/publications/ drug-profiles/synthetic-cannabinoids. Accessed January 19, 2011.
8. Anderson KT, Caravati EM, Crouch BI, Dahl B. Adverse effects associated with smoking damiana incense product. Clin Toxicol. 2010 ; 48: 618
9. Banerji S, Deutsch CM, Bronstein AC. Spice ain't so nice ;. Clin Toxicol. 2010 ; 48: 632
10. Bronstein AC, Spyker DA, Cantilena LR,, Green JL, Rumack BH, Giffin SL. 2009 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th annual report. Clin Toxicol. 2010 ; 48: 979
11. Ragone SP, Geller RJ, Lopez GP. A poison center's development of a media campaign to address trends of herbal incense abuse. Clin Toxicol. 2010 ; 649: 48
12. Forrester MB. Impact of legislation on illicit substance surveillance by poison centers in Texas. J Registry Management. 2005 ; 32: 118-123
13. Reece AS. Chronic toxicology of cannabis. Clin Toxicol. 2009 ; 47: 517-524
14. Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty?. Int J Cardiol. 2007 ; 118: 141-144
15. JohnstonLDO'MalleyPMBachman JG, SchulenbergJE. Marijuana use is rising; ecstasy use is beginning to rise; and alcohol use is declining among U.S. teens. Ann Arbor, MI: University of Michigan News Service. December 14, 2010. Available athttp://www.monitoringthefuture.org. Accessed January 28, 2011.
16. Zimmerman US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "Spice Gold.".. 2009 ; 106: 464-467
17. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002 ; 42: 58S - 63S
18. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002 ; 42: 64S - 70S
19. Logan B, Smith M. Data from Missouri K2 Administration Study. Reported as a part of a presentation, "Spice-pharmacology, chemistry, and clinical effects" at the American College of Medical Toxicology conference on "Forensics of Ethanol and Marijuana." Philadelphia, PA. :
20. Auwarter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. Spice and other herbal blends: harmless incense or cannabinoid designer drugs?. J Mass Spectrom. 2009 ; 44: 832-837
21. Atwood BK, Huffman J, Straiker A, Makcie K. JWH-018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br J Pharmacol. 2010 ; 160: 585-593
22. Wintermeyer A, Möller I, Thevis M, Jübner M, Beike J, Rothschild MA, et al. In vitro phase 1 metabolism of the synthetic cannabimimetic JWH-018. Ann Bioanal Chem. 2010 ; 398: 2141-2153
23. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009 ; 374: 1383-1391
24. Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int. 2010 ; 198: 31-38